Cencora Inc (NYSE: COR), formerly AmerisourceBergen, is a leading pharmaceutical distribution and services company serving healthcare providers, pharmacies, and manufacturers. As one of the "Big Three" U.S. drug wholesalers, Cencora combines logistics scale with value-added solutions in specialty care, supply chain consulting, and patient access programs. It offers investors defensive healthcare exposure, consistent free cash flow, and earnings visibility in global pharmaceutical distribution.
最新股票文章

平頭哥分拆上市分析:阿里巴巴AI芯片業務的結構性風險與估值框架
阿里巴巴旗下平頭哥半導體擬分拆獨立上市,摩根大通估值介於250億至620億美元。本文從業務依賴度、估值方法論、地緣政策風險及港股科技板塊估值溢價等維度,解構該交易的結構性風險與分析框架。
14:16, 11 3月 2026


